FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to a vaccine composition, containing: a) preparation of inactivated whole rabies viruses; b) stabilising excipient, containing (Components - Volume/quantity): essential aminoacids - 40 ml; non-essential amino acids - 40 ml; sorbite - 20 g; arginine hydrochloride - 4 g; EDTA - 0.148 g; sodium glutamate - 1.6 g; Na2HPO4·2H2O - 8/428 g; NaHPO4·2H2O - 0.413 g; Maltose - 50 g; Urea - 4 g; Bringing pH value to 8.0 by an addition of 10 n of a sodium hydroxide solution; Demineralised water in an amount required to: 1000 ml and poloxamer 188 in a concentration of 0.02 g/l or 0.01 g/l, as well as to a method of obtaining the said vaccine composition and stabilising excipient.
EFFECT: group of inventions is effective in stabilisation of vaccines, containing poorly preservable inactivated whole rabies viruses.
16 cl, 2 dwg, 16 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIRABIC INACTIVATED EMULSION CULTURE VACCINE FOR PROPHYLACTIC IMMUNIZATION OF DOMESTIC CARNIVORES AND FARM ANIMALS | 2019 |
|
RU2722868C1 |
| SERUM-FREE ENVIRONMENT “VNIIZZH” FOR THE CULTIVATION OF VNK-21 KIDNEY CELLS OF THE SYRIAN HAMSTER AND THE PRODUCTION OF IMMUNOGENIC COMPONENTS OF CULTURE-BASED VIRUSES OF FOOT-AND-MOUTH DISEASE AND RABIES FOR THE MANUFACTURE OF VACCINES | 2021 |
|
RU2770814C1 |
| TRIMERISED SINGLE-DOMAIN ANTIBODY THAT SPECIFICALLY BINDS WITH GLYCOPROTEIN G OF RABIES VIRUS, NEUTRALISING RABIES VIRUS | 2013 |
|
RU2533802C1 |
| STABILISED VACCINE COMPOSITION FOR STIMULATION OF IMMUNE RESPONSE AND METHOD FOR ITS OBTAINING | 2003 |
|
RU2339400C2 |
| METHOD OF INDIRECT DETERMINATION OF THE COMPLETENESS OF RABIES VIRUS ANTIGEN INACTIVATION USING REVERSE-TRANSCRIPTASE POLYMERASE CHAIN REACTION FOLLOWED BY ELECTROPHORESIS OF AMPLICONS IN AGAROSE GEL | 2020 |
|
RU2746588C1 |
| METHOD FOR PREPARING INACTIVATED ANTIRABIC VACCINE IN FRAMELESS CELL GROWTH AND VIRUS REPLICATION IN SHORT-TERM CULTURE CYCLE | 2012 |
|
RU2537183C2 |
| METHOD FOR SPECTROMETRIC DETERMINATION OF CONCENTRATION OF RABIES VIRUS RIBONUCLEOPROTEIN BY ESTIMATING THE NUMBER OF VIRAL RNA MOLECULES IN RAW MATERIALS FOR RABIES VACCINES | 2020 |
|
RU2748475C1 |
| VACCINE AGAINST PLAGUE, ADENOVIRUS INFECTIONS, PARVOVIRUS AND CORONAVIRUS ENTERITIS, LEPTOSPIROSIS AND RABIES OF DOGS | 2013 |
|
RU2546247C2 |
| METHOD FOR MEDIATED DETERMINATION OF THE TITER OF INFECTIOUS ACTIVITY OF THE RABIES VIRUS OF THE ARRIAH STRAIN IN RAW MATERIALS FOR AN INACTIVATED RABIES VACCINE BY MEANS OF PCR IN REAL TIME | 2020 |
|
RU2755925C1 |
| VIRAL VACCINE | 2003 |
|
RU2268067C2 |
